MaaT Pharma
2014
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Accelerator/Inc
LATEST DEAL TYPE
5
INVESTORS
Description
Provider of microbiotherapy services designed to treat serious diseases linked to imbalances in the intestinal microbiome. The company's microbiotherapy services envisages a first therapeutic application, enabling patients suffering from leukaemia and bone and joint infections get treatment to dysbiosis.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Primary Office
- 317 Avenue Jean Jaurès
- 69007 Lyon
- France
+33 04 00 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore MaaT Pharma’s full profile, request a free trial.
MaaT Pharma Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 29-Oct-2016 | 00.000 | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 22-Mar-2016 | 000.00 | 00.000 | 000.00 | Completed | Startup |
| 2. Early Stage VC | 24-Jul-2015 | $1.11M | $2.32M | Completed | Startup | |
| 1. Seed Round | 09-Jan-2015 | $1.21M | $1.21M | Completed | Startup |
MaaT Pharma Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SynDevRx | Venture Capital-Backed | Cambridge, MA | 0 | 000.00 | 0000000000 0 | 000.00 |
| 00000 000000000000 | Venture Capital-Backed | Somerville, MA | 00 | 00000 | 0000000000 0 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 000.00 | 00000000000 | 000.00 |
| 00 00000000 | Private Debt Financed | Paris, France | 00 | 000.00 | 000000000 | 000.00 |
| 0000000000 000000 | Venture Capital-Backed | York, United Kingdom | 00.000 | 000000000 | 00.000 |
MaaT Pharma Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| BigBooster | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Biocodex | Corporation | Minority | 000 0000 | 000000 0 | ||
| CM-CIC Capital Innovation | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| INRA Transfert | Other | Minority | 000 0000 | 000000 0 | ||
| Seventure Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
MaaT Pharma Executive Team (5)
MaaT Pharma Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Eric de La Fortelle Ph.D | Seventure Partners | Board Member | 000 0000 | |
| Herve Affagard | MaaT Pharma | Co-Founder, Board Member & Chief Executive Officer | 000 0000 | |
| Isabelle de Cremoux | Seventure Partners | Board Member | 000 0000 | |
| Jean-Marie Lefevre | Biocodex | Board Member | 000 0000 | |
| Julien Samson | Self | Board Member | 000 0000 |